An update on CRF mechanisms underlying alcohol use disorders and dependence

Frontiers in Endocrinology

Volumn 7, Issue OCT, 2016, Pages

  Quadros, Isabel Marian Hartmann ^a   Macedo, Giovana Camila ^a   Domingues, Liz Paola ^a   Favoretto, Cristiane Aparecida ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Addiction; Alcohol; Alcohol self administration; Alcohol related aggression; Animal models; Mesocorticolimbic system; Neuropeptides; Sensitization

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; UROCORTIN; UROCORTIN I; UROCORTIN II; UROCORTIN III;

AGGRESSION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL SYNDROME; ALCOHOLISM; ANXIETY; BEHAVIOR CHANGE; BINGE DRINKING; BRAIN FUNCTION; DNA POLYMORPHISM; DRINKING BEHAVIOR; DRUG SEEKING BEHAVIOR; GENETIC MANIPULATION; GENOTYPE ENVIRONMENT INTERACTION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROMODULATION; NONHUMAN; PLACE PREFERENCE; RELAPSE; REVIEW; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SOCIAL PHOBIA; STRESS; WITHDRAWAL SYNDROME;

EID: 84995474935     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00134     Document Type: Review

References (220)

1. Koob GF, Buck CL, Cohen A, Edwards S, Park PE, Schlosburg JE, et al. Addiction as a stress surfeit disorder. Neuropharmacology (2014) 76:370-82. doi:10.1016/j.neuropharm.2013.05.024
2. Stephens MA, Wand G. Stress and the HPA axis: role of glucocorticoids in alcohol dependence. Alcohol Res (2012) 34(4):468-83.
3. Edwards S, Little HJ, Richardson HN, Vendruscolo LF. Divergent regulation of distinct glucocorticoid systems in alcohol dependence. Alcohol (2015) 49(8):811-6. doi:10.1016/j.alcohol.2015.04.004
4. Phillips TJ, Reed C, Pastor R. Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation. Genes Brain Behav (2015) 14(1):98-135. doi:10.1111/gbb.12189
5. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 30(8):399-406. doi:10.1016/j.tins.2007.06.006.A
6. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev (2001) 53:209-43.
7. Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol (2014) 35:234-44. doi:10.1016/j.yfrne.2014.01.001
8. WHO. Global Information System on Alcohol and Health. World Health Statistics (2014). Available from: http://www.who.int/gho/publications/world_health_statistics/EN_WHS2014_Part3.pdf
9. Gowing LR, Ali RL, Allsop S, Marsden J, Turf EE, West R, et al. Global statistics on addictive behaviours: 2014 status report. Addiction (2015) 110(6):904-19. doi:10.1111/add.12899
10. WHO. International Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization (1992).
11. Sanchis-Segura C, Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol (2006) 11(1):2-38. doi:10.1111/j.1369-1600.2006.00012.x
12. Spanagel R, Hölter SM. Pharmacological validation of a new animal model of alcoholism. J Neural Transm (2000) 107(6):669-80. doi:10.1007/s007020070068
13. Fachin-Scheit DJ, Ribeiro AF, Pigatto G, Goeldner FO, de Lacerda RB. Development of a mouse model of ethanol addiction: naltrexone efficacy in reducing consumption but not craving. J Neural Transm (2006) 113(9):1305-21. doi:10.1007/s00702-005-0416-z
14. Wolffgramm J. An ethopharmacological approach to the development of drug addiction. Neurosci Biobehav Rev (1991) 15(4):515-9. doi:10.1016/S0149-7634(05)80142-3
15. Goldstein DB, Pal N. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science (1971) 172(3980):288-90. doi:10.1126/science.172.3980.288
16. Rogers J, Wiener SG, Bloom FE. Long-term ethanol administration methods for rats: advantages of inhalation over intubation or liquid diets. Behav Neural Biol (1979) 27(4):466-86. doi:10.1016/S0163-1047(79)92061-2
17. Becker HC. Behavioral neurobiology of alcohol addiction. In: Sommer WH, Spanagel R, editors. Current Topics in Behavioral Neurosciences. Vol. 13. Berlin, Heidelberg: Springer Berlin Heidelberg (2013).
18. Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS, et al. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol Psychiatry (2008) 63(2):139-45. doi:10.1016/j.biopsych.2007.01.010
19. Lovinger DM, Roberto M. Synaptic effects induced by alcohol. Curr Top Behav Neurosci (2013) 13:31-86. doi:10.1007/7854_2011_143
20. Siggins GR, Roberto M, Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol Ther (2005) 107(1):80-98. doi:10.1016/j.pharmthera.2005.01.006
21. Chandler LJ, Sutton G, Norwood D, Sumners C, Crews FT. Chronic ethanol increases N-methyl-d-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol Pharmacol (1997) 51(5):733-40.
22. Chandler LJ, Norwood D, Sutton G. Chronic ethanol upregulates NMDA and AMPA, but not kainate receptor subunit proteins in rat primary cortical cultures. Alcohol Clin Exp Res (1999) 23(2):363-70. doi:10.1111/j.1530-0277.1999.tb04123.x
23. Lack AK, Diaz MR, Chappell A, DuBois DW, McCool BA. Chronic ethanol and withdrawal differentially modulate pre-and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J Neurophysiol (2007) 98(6):3185-96. doi:10.1152/jn.00189.2007
24. Roberto M, Cruz MT, Gilpin NW, Sabino V, Schweitzer P, Bajo M, et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol Psychiatry (2010) 67(9):831-9. doi:10.1016/j.biopsych.2009.11.007
25. Cozzoli DK, Goulding SP, Zhang PW, Xiao B, Hu JH, Ary AW, et al. Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J Neurosci (2009) 29(27):8655-68. doi:10.1523/JNEUROSCI.5900-08.2009
26. Grobin AC, Matthews DB, Devaud LL, Morrow AL. The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacology (1998) 139(1-2):2-19. doi:10.1007/s002130050685
27. Kumar S, Porcu P, Werner DF, Matthews DB, Diaz-Granados JL, Helfand RS, et al. The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (2009) 205(4):529-64. doi:10.1007/s00213-009-1562-z
28. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science (1981) 213(4514):1394-7. doi:10.1126/science.6267699
29. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko P, Vale WW. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol (1995) 16(4):362-82. doi:10.1006/frne.1995.1013
30. Seasholtz AF, Valverde RA, Denver RJ. Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol (2002) 175(1):89-97. doi:10.1677/joe.0.1750089
31. Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol (2004) 44(January):525-57. doi:10.1146/annurev.pharmtox.44.101802.121410
32. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci U S A (1995) 92(7):2969-73. doi:10.1073/pnas.92.7.2969
33. Fekete EM, Zorrilla EP. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol (2007) 28(1):1-27. doi:10.1016/j.yfrne.2006.09.002
34. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci (1999) 885:312-28. doi:10.1111/j.1749-6632.1999.tb08687.x
35. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol (2000) 428(2):191-212. doi:10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U
36. Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci (1995) 15(10):6340-50.
37. Lovenberg TW, Chalmers DT, Liu C, De Souza EB. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology (1995) 136(9):4139-42. doi:10.1210/endo.136.9.7544278
38. Pan W, Kastin AJ. Urocortin and the brain. Prog Neurobiol (2008) 84(2):148-56. doi:10.1016/j.pneurobio.2007.10.008
39. Stengel A, Taché Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (2010) 235(10):1168-78. doi:10.1258/ebm.2010.009347
40. Rivier C, Rivier J, Vale W. Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science (1982) 218(4570):377-9. doi:10.1126/science.6289439
41. Rivier C, Bruhn T, Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther (1984) 229(1):127-31. doi:10.1111/j.1530-0277.2001.tb02133.x
42. Papadimitriou A, Priftis KN. Regulation of the hypothalamic-pituitary-adrenal axis. Neuroimmunomodulation (2009) 16(5):265-71. doi:10.1159/000216184
43. Scott LV, Dinan TG. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. Life Sci (1998) 62(22):1985-98. doi:10.1016/S0024-3205(98)00027-7
44. Steckler T, Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry (1999) 46(11):1480-508. doi:10.1016/S0006-3223(99)00170-5
45. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol (2003) 24(3):151-80. doi:10.1016/j.yfrne.2003.07.001
46. McEwen BS. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem Res (2000) 25(9-10):1219-31. doi:10.1023/A:1007687911139
47. Myers B, McKlveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol (2014) 35(2):180-96. doi:10.1016/j.yfrne.2013.12.003
48. Sapolsky RM. Stress hormones: good and bad. Neurobiol Dis (2000) 7(5):540-2. doi:10.1006/nbdi.2000.0350
49. Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci (2009) 10(6):397-409. doi:10.1038/nrn2647
50. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience (1999) 92:281-91. doi:10.1016/S0306-4522(98)00732-5
51. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 36:165-86. doi:10.1159/000123454
52. Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, et al. Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain. Peptides (1998) 19(4):643-7. doi:10.1016/S0196-9781(98)00012-6
53. Vasconcelos LA, Donaldson C, Sita LV, Casatti CA, LotfiCF, Wang L, et al. Urocortin in the central nervous system of a primate (Cebus apella): sequencing, immunohistochemical, and hybridization histochemical characterization. J Comp Neurol (2003) 463(2):157-75. doi:10.1002/cne.10742
54. Stengel A, Taché Y. CRF and urocortin peptides as modulators of energy balance and feeding behavior during stress. Front Neurosci (2014) 8:52. doi:10.3389/fnins.2014.00052
55. Hostetler CM, Ryabinin AE. The CRF system and social behavior: a review. Front Neurosci (2013) 7:92. doi:10.3389/fnins.2013.00092
56. Koob GF, Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res (1999) 848(1-2):141-52. doi:10.1016/S0006-8993(99)01991-5
57. Valentino RJ, Commons KG. Peptides that fine-tune the serotonin system. Neuropeptides (2005) 39(1):1-8. doi:10.1016/j.npep.2004.09.005
58. Valentino RJ, Lucki I, Van Bockstaele E. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res (2010) 1314:29-37. doi:10.1016/j.brainres.2009.09.100
59. Ryabinin AE, Tsoory MM, Kozicz T, Thiele TE, Neufeld-Cohen A, Chen A, et al. Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior. Alcohol (2012) 46(4):349-57. doi:10.1016/j.alcohol.2011.10.007
60. Borgland SJ, Ungless MA, Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res (2010) 1314:139-44. doi:10.1016/j.brainres.2009.10.068
61. George O, Le Moal M, Koob GF. Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav (2011) 106:58-64. doi:10.1016/j.physbeh.2011.11.004
62. Van Bockstaele EJ, Valentino RJ. Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responses. Adv Pharmacol (2013) 68:405-20. doi:10.1016/B978-0-12-411512-5.00019-1
63. Rodaros D, Caruana DA, Amir S, Stewart J. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience (2007) 150(1):8-13. doi:10.1016/j.neuroscience.2007.09.043
64. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A. Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol (2008) 586(8):2157-70. doi:10.1113/jphysiol.2007.150078
65. Lemos JC, Wanat MJ, Smith JS, Reyes BA, Hollon NG, Van Bockstaele EJ, et al. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature (2012) 490(7420):402-6. doi:10.1038/nature11436
66. Holly EN, Miczek KA. Ventral tegmental area dopamine revisited: effects of acute and repeated stress. Psychopharmacology (2016) 233(2):163-86. doi:10.1007/s00213-015-4151-3
67. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci (2005) 25(22):5389-96. doi:10.1523/JNEUROSCI.0955-05.2005
68. Wang B, You ZB, Rice KC, Wise RA. Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (2007) 193(2):283-94. doi:10.1007/s00213-007-0782-3
69. Holly EN, Boyson CO, Montagud-Romero S, Stein DJ, Gobrogge KL, DeBold JF, et al. Episodic social stress-escalated cocaine self-administration: role of phasic and tonic corticotropin releasing factor in the anterior and posterior ventral tegmental area. J Neurosci (2016) 36(14):4093-105. doi:10.1523/JNEUROSCI.2232-15.2016
70. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Björk K, Soverchia L, et al. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A (2006) 103(41):15236-41. doi:10.1073/pnas.0604419103
71. Lodge DJ, Lawrence AJ. The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience (2003) 117(2):243-7. doi:10.1016/S0306-4522(02)00793-5
72. Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, et al. Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav (2012) 100(3):522-9. doi:10.1016/j.pbb.2011.10.016
73. Lowery-Gionta EG, Navarro M, Li C, Pleil KE, Rinker JA, Cox BR, et al. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J Neurosci (2012) 32(10):3405-13. doi:10.1523/jneurosci.6256-11.2012
74. Hwa LS, Debold JF, Miczek KA. Alcohol in excess: CRF1 receptors in the rat and mouse VTA and DRN. Psychopharmacology (2013) 225(2):313-27. doi:10.1007/s00213-012-2820-z
75. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav (2007) 86(4):813-21. doi:10.1016/j.pbb.2007.03.009
76. Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res (2008) 32(2):259-65. doi:10.1111/j.1530-0277.2007.00575.x
77. Giardino WJ, Ryabinin AE. CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption. Alcohol Clin Exp Res (2013) 37(7):1161-70. doi:10.1111/acer.12076
78. Molander A, Vengeliene V, Heilig M, Wurst W, Deussing JM, Spanagel R. Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking. Neuropsychopharmacology (2012) 37(4):1047-56. doi:10.1038/npp.2011.297
79. Yang X, Wang S, Rice KC, Munro CA, Wand GS. Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin Exp Res (2008) 32(5):840-52. doi:10.1111/j.1530-0277.2008.00632.x
80. Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (2007) 195(3):345-55. doi:10.1007/s00213-007-0905-x
81. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2007) 61(1):78-86. doi:10.1016/j.biopsych.2006.03.063
82. Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (2000) 150(3):317-24. doi:10.1007/s002130000411
83. Correia D, Martynhak BJ, Pereira M, Siba IP, Ribeiro AF, Camarini R, et al. Reduction of ethanol intake by corticotropin-releasing factor receptor-1 antagonist in 'heavy-drinking' mice in a free-choice paradigm. Psychopharmacology (2015) 232(15):2731-9. doi:10.1007/s00213-015-3909-y
84. Hwa LS, Shimamoto A, Kayyali T, Norman KJ, Valentino RJ, DeBold JF, et al. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice. Addict Biol (2016) 21:111-24. doi:10.1111/adb.12189
85. Lowery EG, Sparrow AM, Breese GR, Knapp DJ, Thiele TE. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol Clin Exp Res (2008) 32(2):240-8. doi:10.1111/j.1530-0277.2007.00573.x
86. Lowery EG, Spanos M, Navarro M, Lyons AM, Hodge CW, Thiele TE. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology (2010) 35(6):1241-52. doi:10.1038/npp.2009.209
87. Overstreet DH, Knapp DJ, Breese GE. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcohol Clin Exp Res (2007) 31(9):1473-81. doi:10.1111/j.1530-0277.2007.00445.x
88. Sparta DR, Ferraro FM, Fee JR, Knapp DJ, Breese GR, Thiele TE. The alcohol deprivation effect in C57BL/6J mice is observed using operant self-administration procedures and is modulated by CRF-1 receptor signaling. Alcohol Clin Exp Res (2009) 33(1):31-42. doi:10.1111/j.1530-0277.2008.00808.x
89. Sparta DR, Hopf FW, Gibb SL, Cho SL, Stuber GD, Messing RO, et al. Binge ethanol-drinking potentiates corticotropin releasing factor R1 receptor activity in the ventral tegmental area. Alcohol Clin Exp Res (2013) 37(10):1680-7. doi:10.1111/acer.12153
90. Simms JA, Nielsen CK, Li R, Bartlett SE. Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. Addict Biol (2014) 19(4):606-11. doi:10.1111/adb.12024
91. Overstreet DH, Knapp DJ, Breese GR. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol Biochem Behav (2004) 77(2):405-13. doi:10.1016/j.pbb.2003.11.010
92. Sabino V, Cottone P, Koob GF, Steardo L, Lee MJ, Rice KC, et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (2006) 189(2):175-86. doi:10.1007/s00213-006-0546-5
93. Gilpin NW, Richardson HN, Koob GF. Effects of CRF 1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res (2008) 32(9):1535-42. doi:10.1111/j.1530-0277.2008.00745.x
94. Richardson HN, Zhao Y, Fekete EM, Funk CK, Wirsching P, Janda KD, et al. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol Biochem Behav (2008) 88(4):497-510. doi:10.1016/j.pbb.2007.10.008
95. Ji D, Gilpin NW, Richardson HN, Rivier CL, Koob GF. Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behav Pharmacol (2008) 19(1):1-12. doi:10.1097/FBP.0b013e3282f3cf70
96. Gehlert DR, Cippitelli A, Thorsell A, Lê AD, Hipskind PA, Hamdouchi C, et al. 3-(4-chloro-2-morpholin-4-Yl-thiazol-5-Yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-B]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci (2007) 27(10):2718-26. doi:10.1523/jneurosci.4985-06.2007
97. Sabino V, Kwak J, Rice KC, Cottone P. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res (2013) 37(4):635-43. doi:10.1111/acer.12008
98. Roltsch EA, Baynes BB, Mayeux JP, Whitaker AM, Baiamonte BA, Gilpin NW. Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats. Neuropharmacology (2014) 79(April):83-9. doi:10.1016/j.neuropharm.2013.11.005
99. Knapp DJ, Overstreet DH, Huang M, Wills TA, Whitman BA, Angel RA, et al. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology (2011) 218(1):179-89. doi:10.1007/s00213-011-2366-5
100. O'Callaghan MJ, Croft AP, Jacquot C, Little HJ. The hypothalamopituitary-adrenal axis and alcohol preference. Brain Res Bull (2005) 68(3):171-8. doi:10.1016/j.brainresbull.2005.08.006
101. Bell SM, Reynolds JG, Thiele TE, Gan J, Figlewicz DP, Woods SC. Effects of third intracerebroventricular injections of corticotropin-releasing factor (CRF) on ethanol drinking and food intake. Psychopharmacology (1998) 139(1-2):128-35. doi:10.1007/s002130050697
102. Thorsell A, Slawecki CJ, Ehlers CL. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav Brain Res (2005) 161(1):133-40. doi:10.1016/j.bbr.2005.01.016
103. Le AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci (2002) 22(18):7844-9.
104. Weitemier AZ, Ryabinin AE. Urocortin 1 in the dorsal raphe regulates food and fluid consumption, but not ethanol preference in C57BL/6J mice. Neuroscience (2006) 137(4):1439-45. doi:10.1016/j.neuroscience.2005.10.021
105. Ryabinin AE, Yoneyama N, Tanchuck MA, Mark GP, Finn DA. Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience (2008) 151(3):780-90. doi:10.1016/j.neuroscience.2007.11.014
106. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res (2002) 26(10):1494-501. doi:10.1111/j.1530-0277.2002.tb02448.x
107. Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci (2002) 22(18):7856-61.
108. Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M, et al. Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). Alcohol Clin Exp Res (2007) 31(6):939-49. doi:10.1111/j.1530-0277.2007.00379.x
109. Funk CK, O'Dell LE, Crawford EF, Koob GF. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci (2006) 26(44):11324-32. doi:10.1523/JNEUROSCI.3096-06.2006
110. Funk D, Li Z, Lê AD. Effects of environmental and pharmacological stressors on c-Fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience (2006) 138(1):235-43. doi:10.1016/j.neuroscience.2005.10.062
111. Le AD, Funk D, Coen K, Li Z, Shaham Y. Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats. Addict Biol (2013) 18(3):448-51. doi:10.1111/j.1369-1600.2011.00374.x
112. Sharpe AL, Phillips TJ. Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav Pharmacol (2009) 20(4):346-51. doi:10.1097/FBP.0b013e32832f01ba
113. Valdez GR, Sabino V, Koob GF. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol Clin Exp Res (2004) 28(6):865-72. doi:10.1097/01.ALC.0000128222.29875.40
114. Funk CK, Koob GF. A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res (2007) 1155(June):172-8. doi:10.1016/j.brainres.2007.04.009
115. Albrechet-Souza L, Hwa LS, Han X, Zhang WY, DeBold JF, Miczek KA. Corticotropin releasing factor binding protein and CRF2 receptors in the ventral tegmental area: modulation of ethanol binge drinking in C57BL/6J mice. Alcohol Clin Exp Res (2015) 39(9):1609-18. doi:10.1111/acer.12825
116. Cunningham CL, Gremel CM, Groblewski PA. Drug-induced conditioned place preference and aversion in mice. Nat Protoc (2006) 1(4):1662-70. doi:10.1038/nprot.2006.279
117. Huston JP, Silva MAS, Topic B, Müller CP. What's conditioned in conditioned place preference? Trends Pharmacol Sci (2013) 34(3):162-6. doi:10.1016/j.tips.2013.01.004
118. Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol (2007) 12(3-4):227-462. doi:10.1111/j.1369-1600.2007.00070.x
119. Olive MF, Mehmert KK, Koenig HN, Camarini R, Kim JA, Nannini MA, et al. A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice. Psychopharmacology (2003) 165(2):181-7. doi:10.1007/s00213-002-1248-2
120. Giardino WJ, Cocking DL, Kaur S, Cunningham CL, Ryabinin AE. Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS One (2011) 6(10):e26997. doi:10.1371/journal.pone.0026997
121. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev (1993) 18(3):247-91. doi:10.1016/0165-0173(93)90013-P
122. Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction (2001) 96(1):103-14. doi:10.1080/09652140020016996
123. Steketee JD, Kalivas PW. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev (2011) 63(2):348-65. doi:10.1124/pr.109.001933
124. Vanderschuren LJMJ, Pierce RC. Sensitization processes in drug addiction. Curr Top Behav Neurosci (2010) 3:179-95. doi:10.1007/7854_2009_21
125. Abrahao KP, Souza-Formigoni MLO. Behavioral sensitization to ethanol results in cross-sensitization to MK-801 but not to NMDA administered intra-accumbens. Behav Brain Res (2012) 235(2):218-24. doi:10.1016/j.bbr.2012.07.034
126. Masur J, Boerngen R. The excitatory component of ethanol in mice: a chronic study. Pharmacol Biochem Behav (1980) 13(6):777-80. doi:10.1016/0091-3057(80)90206-3
127. Post RM, Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature (1976) 260(5553):731-2. doi:10.1038/260731a0
128. Quadros IMH, Nobrega JN, Hipólide DC, de Lucca EM, Souza-Formigoni MLO. Differential propensity to ethanol sensitization is not associated with altered binding to D1 receptors or dopamine transporters in mouse brain. Addict Biol (2002) 7(3):291-9. doi:10.1080/13556210220139505
129. Segal DS, Mandell AJ. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav (1974) 2(2):249-55. doi:10.1016/0091-3057(74)90060-4
130. Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD. Locomotor stimulant effects of intraventricular injections of low doses of ethanol in rats: acute and repeated administration. Psychopharmacology (2003) 170(4):368-75. doi:10.1007/s00213-003-1557-0
131. Hoshaw BA, Lewis MJ. Behavioral sensitization to ethanol in rats: evidence from the Sprague-Dawley strain. Pharmacol Biochem Behav (2001) 68(4):685-90. doi:10.1016/S0091-3057(01)00489-0
132. Camarini R, Hodge CW. Ethanol preexposure increases ethanol self-administration in C57BL/6J and DBA/2J mice. Pharmacol Biochem Behav (2004) 79(4):623-32. doi:10.1016/j.pbb.2004.09.012
133. Masur J, Oliveira de Souza ML, Zwicker AP. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav (1986) 24(5):1225-8. doi:10.1016/0091-3057(86)90175-9
134. Phillips TJ, Dickinson S, Burkhart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci (1994) 108(4):789-803. doi:10.1037/0735-7044.108.4.789
135. Phillips TJ, Huson M, Gwiazdon C, Burkhart-Kasch S, Shen EH. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res (1995) 19(2):269-78. doi:10.1111/j.1530-0277.1995.tb01502.x
136. Schwandt ML, Higley JD, Suomi SJ, Heilig M, Barr CS. Rapid tolerance and locomotor sensitization in ethanol-naïve adolescent rhesus macaques. Alcohol Clin Exp Res (2008) 32(7):1217-28. doi:10.1111/j.1530-0277.2008.00676.x
137. Newlin DB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics. Alcohol Clin Exp Res (1991) 15(3):399-405. doi:10.1111/j.1530-0277.1991.tb00537.x
138. Newlin DB, Thomson JB. Chronic tolerance and sensitization to alcohol in sons of alcoholics: II. Replication and reanalysis. Exp Clin Psychopharmacol (1999) 7(3):234-43. doi:10.1037/1064-1297.7.3.234
139. Pastor R, McKinnon CS, Scibelli AC, Burkhart-Kasch S, Reed C, Ryabinin AE, et al. Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proc Natl Acad Sci U S A (2008) 105(26):9070-5. doi:10.1073/pnas.0710181105
140. Pastor R, Reed C, Meyer PJ, McKinnon C, Ryabinin AE, Phillips TJ. Role of corticotropin-releasing factor and corticosterone in behavioral sensitization to ethanol. J Pharmacol Exp Ther (2012) 341(2):455-63. doi:10.1124/jpet.111.190595
141. Fee JR, Sparta DR, Picker MJ, Thiele TE. Corticotropin releasing factor-1 receptor antagonist, CP-154,526, blocks the expression of ethanol-induced behavioral sensitization in DBA/2J mice. Neuroscience (2007) 150(1):14-21. doi:10.1016/j.neuroscience.2007.08.027
142. Kawakami SE, Quadros IMH, Takahashi S, Suchecki D. Long maternal separation accelerates behavioural sensitization to ethanol in female, but not in male mice. Behav Brain Res (2007) 184(2):109-16. doi:10.1016/j.bbr.2007.06.023
143. Kawakami SE, Quadros IMH, Machado RB, Suchecki D. Sex-dependent effects of maternal separation on plasma corticosterone and brain monoamines in response to chronic ethanol administration. Neuroscience (2013) 253:55-66. doi:10.1016/j.neuroscience.2013.08.031
144. Roberts AJ, Lessov CN, Phillips TJ. Critical role for glucocorticoid receptors in stress-and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther (1995) 275(2):790-7.
145. Quadros IM, Hwa LS, Shimamoto A, Carlson J, DeBold JF, Miczek KA. Prevention of alcohol-heightened aggression by CRF-R1 antagonists in mice: critical role for DRN-PFC serotonin pathway. Neuropsychopharmacology (2014) 39(12):2874-83. doi:10.1038/npp.2014.139
146. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat. Psychopharmacology (1991) 103(2):227-32. doi:10.1007/BF02244208
147. Rassnick S, Heinrichs SC, Britton KT, Koob GF. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 605(1):25-32. doi:10.1016/0006-8993(93)91352-S
148. Valdez GR, Zorrilla EP, Roberts AJ, Koob GF. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol (2003) 29(2):55-60. doi:10.1016/S0741-8329(03)00020-X
149. Breese GR, Overstreet DH, Knapp DJ, Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1-and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology (2005) 30(9):1662-9. doi:10.1038/sj.npp.1300706
150. Wills TA, Knapp DJ, Overstreet DH, Breese GR. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcohol Clin Exp Res (2009) 33(3):455-63. doi:10.1111/j.1530-0277.2008.00856.x
151. Overstreet DH, Knapp DJ, Breese GR. Pharmacological modulation of repeated ethanol withdrawal-induced anxiety-like behavior differs in alcohol-preferring P and Sprague-Dawley rats. Pharmacol Biochem Behav (2005) 81(1):122-30. doi:10.1016/j.pbb.2005.03.006
152. Breese GR, Knapp DJ, Overstreet DH. Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist. Neuropsychopharmacology (2004) 29(3):470-82. doi:10.1038/sj.npp.1300282
153. Knapp DJ, Overstreet DH, Moy SS, Breese GR. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol (2004) 32(2):101-11. doi:10.1016/j.alcohol.2003.08.007
154. Huang MM, Overstreet DH, Knapp DJ, Angel R, Wills TA, Navarro M, et al. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. J Pharmacol Exp Ther (2010) 332(1):298-307. doi:10.1124/jpet.109.159186
155. Knapp DJ, Whitman BA, Wills TA, Angel RA, Overstreet DH, Criswell HE, et al. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav Immun (2011) 25(Suppl1):S146-54. doi:10.1016/j.bbi.2011.02.018
156. Miczek KA, Faccidomo S, De Almeida RMM, Bannai M, Fish EW, Debold JF. Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Ann N Y Acad Sci (2004) 1036:336-55. doi:10.1196/annals.1330.021
157. Miczek KA, Takahashi A, Gobrogge KL, Hwa LS, de Almeida RMM. Escalated aggression in animal models: shedding new light on mesocorticolimbic circuits. Curr Opin Behav Sci (2015) 3:90-5. doi:10.1016/j.cobeha.2015.02.007
158. Chiavegatto S, Quadros IMH, Ambar G, Miczek KA. Individual vulnerability to escalated aggressive behavior by a low dose of alcohol: decreased serotonin receptor mRNA in the prefrontal cortex of male mice. Genes Brain Behav (2010) 9(1):110-9. doi:10.1111/j.1601-183X.2009.00544.x
159. Faccidomo S, Bannai M, Miczek KA. Escalated aggression after alcohol drinking in male mice: dorsal raphé and prefrontal cortex serotonin and 5-HT(1B) receptors. Neuropsychopharmacology (2008) 33(12):2888-99. doi:10.1038/npp.2008.7
160. Faccidomo S, Quadros IM, Takahashi A, Fish EW, Miczek KA. Infralimbic and dorsal raphé microinjection of the 5-HT(1B) receptor agonist CP-93,129: attenuation of aggressive behavior in CFW male mice. Psychopharmacology (2012) 222(1):117-28. doi:10.1007/s00213-011-2629-1
161. Miczek KA, de Almeida RM. Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (2001) 157(4):421-9. doi:10.1007/s002130100831
162. Fox JH, Lowry CA. Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci (2013) 7:169. doi:10.3389/fnins.2013.00169
163. Rose AK, Shaw SG, Prendergast MA, Little HJ. The importance of glucocorticoids in alcohol dependence and neurotoxicity. Alcohol Clin Exp Res (2010) 34(12):2011-8. doi:10.1111/j.1530-0277.2010.01298.x
164. Rivier C, Lee S. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin. Brain Res (1996) 726(1-2):1-10. doi:10.1016/0006-8993(96)00301-0
165. Rivier C, Rivier J, Lee S. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res (1996) 721(1-2):83-90. doi:10.1016/0006-8993(96)00164-3
166. Redei E, Rittenhouse PA, Revskoy S, McGivern RF, Aird F. A novel endogenous corticotropin release inhibiting factor. Ann N Y Acad Sci (1998) 840:456-69. doi:10.1111/j.1749-6632.1998.tb09584.x
167. Ogilvie K, Lee S, Rivier C. Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res (1997) 21(3):467-76. doi:10.1111/j.1530-0277.1997.tb03792.x
168. Ogilvie KM, Lee S, Rivier C. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei. Brain Res (1997) 744(1):83-95. doi:10.1016/S0006-8993(96)01082-7
169. Laszlo FA, Varga C, Pávó I, Gardi J, Vecsernyés M, GálfiM, et al. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats. Am J Physiol Regul Integr Comp Physiol (2001) 280(2):R458-65.
170. Rivier C, Imaki T, Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF-and stress-induced ACTH secretion in the rat. Brain Res (1990) 520:1-5. doi:10.1016/0006-8993(90)91685-A
171. Lee S, Imaki T, Vale W, Rivier C. Effect of prenatal exposure to ethanol on the activity of the hypothalamic-pituitary-adrenal axis of the offspring: importance of the time of exposure to ethanol and possible modulating mechanisms. Mol Cell Neurosci (1990) 1(2):168-77. doi:10.1016/1044-7431(90)90022-V
172. Zhou Y, Franck J, Spangler R, Maggos CE, Ho A, Kreek MJ. Reduced hypothalamic POMC and anterior pituitary CRF1 receptor mRNA levels after acute, but not chronic, daily 'binge' intragastric alcohol administration. Alcohol Clin Exp Res (2000) 24(10):1575-82. doi:10.1111/j.1530-0277.2000.tb04577.x
173. Glavas MM, Ellis L, Yu WK, Weinberg J. Effects of prenatal ethanol exposure on basal limbic-hypothalamic-pituitary-adrenal regulation: role of corticosterone. Alcohol Clin Exp Res (2007) 31(9):1598-610. doi:10.1111/j.1530-0277.2007.00460.x
174. Lee S, Selvage D, Hansen K, Rivier C. Site of action of acute alcohol administration in stimulating the rat hypothalamic-pituitary-adrenal axis: comparison between the effect of systemic and intracerebroventricular injection of this drug on pituitary and hypothalamic responses. Endocrinology (2004) 145(10):4470-9. doi:10.1210/en.2004-0110
175. Logrip ML, Rivier C, Lau C, Im S, Vaughan J, Lee S. Adolescent alcohol exposure alters the rat adult hypothalamic-pituitary-adrenal axis responsiveness in a sex-specific manner. Neuroscience (2013) 235:174-86. doi:10.1016/j.neuroscience.2012.12.069
176. Lee S, Rivier C. Alcohol increases the expression of type 1, but not type 2 alpha corticotropin-releasing factor (CRF) receptor messenger ribonucleic acid in the rat hypothalamus. Brain Res Mol Brain Res (1997) 52(1):78-89. doi:10.1016/S0169-328X(97)00226-X
177. Lee S, Schmidt ED, Tilders FJ, Rivier C. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. role of changes in hypothalamic neuronal activity. Alcohol Clin Exp Res (2001) 25(1):98-105. doi:10.1111/j.1530-0277.2001.tb02132.x
178. Lee S, Smith GW, Vale W, Lee KF, Rivier C. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Alcohol Clin Exp Res (2001) 25(3):427-33. doi:10.1111/j.1530-0277.2001.tb02231.x
179. Falco AM, Bergstrom HC, Bachus SE, Smith RF. Persisting changes in basolateral amygdala mRNAs after chronic ethanol consumption. Physiol Behav (2009) 96(1):169-73. doi:10.1016/j.physbeh.2008.09.019
180. Eisenhardt M, Hansson AC, Spanagel R, Bilbao A. Chronic intermittent ethanol exposure in mice leads to an up-regulation of CRH/CRHR1 signaling. Alcohol Clin Exp Res (2015) 39(4):752-62. doi:10.1111/acer.12686
181. Allen CD, Rivier CL, Lee SY. Adolescent alcohol exposure alters the central brain circuits known to regulate the stress response. Neuroscience (2011) 182:162-8. doi:10.1016/j.neuroscience.2011.03.003
182. Merlo-Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci (1995) 15(8):5439-47.
183. Olive MF, Koenig HN, Nannini MA, Hodge CW. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav (2002) 72(1-2):213-20. doi:10.1016/S0091-3057(01)00748-1
184. Lam MP, Gianoulakis C. Effects of acute ethanol on corticotropin-releasing hormone and β-endorphin systems at the level of the rat central amygdala. Psychopharmacology (2011) 218(1):229-39. doi:10.1007/s00213-011-2337-x
185. Caldwell KK, Goggin SL, Tyler CR, Allan AM. Prenatal alcohol exposure is associated with altered subcellular distribution of glucocorticoid and mineralocorticoid receptors in the adolescent mouse hippocampal formation. Alcohol Clin Exp Res (2014) 38(2):392-400. doi:10.1111/acer.12236
186. Li Z, Kang SS, Lee S, Rivier C. Effect of ethanol on the regulation of corticotropin-releasing factor (CRF) gene expression. Mol Cell Neurosci (2005) 29(3):345-54. doi:10.1016/j.mcn.2005.04.002
187. Pickering C, Avesson L, Lindblom J, Liljequist S, Schiöth HB. Identification of neurotransmitter receptor genes involved in alcohol self-administration in the rat prefrontal cortex, hippocampus and amygdala. Prog Neuropsychopharmacol Biol Psychiatry (2007) 31(1):53-64. doi:10.1016/j.pnpbp.2006.06.010
188. Hansson AC, Cippitelli A, Sommer WH, Ciccocioppo R, Heilig M. Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict Biol (2007) 12(1):30-4. doi:10.1111/j.1369-1600.2007.00050.x
189. McClintick JN, McBride WJ, Bell RL, Ding Z, Liu Y, Xuei X, et al. Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking. Pharmacol Biochem Behav (2015) 129:87-96. doi:10.1016/j.pbb.2014.12.007
190. Pickering C, Avesson L, Liljequist S, Lindblom J, Schiöth HB. the Role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides (2007) 28(12):2361-71. doi:10.1016/j.peptides.2007.09.011
191. Weitemier AZ, Ryabinin AE. Brain region-specific regulation of urocortin 1 innervation and corticotropin-releasing factor receptor type 2 binding by ethanol exposure. Alcohol Clin Exp Res (2005) 29(9):1610-20. doi:10.1097/01.alc.0000179363.44542.05
192. Rivier C. Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis. Front Neuroendocrinol (2014) 35(2):221-33. doi:10.1016/j.yfrne.2013.10.005
193. Läck AK, Floyd DW, McCool BA. Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol (2005) 36(2):83-90. doi:10.1016/j.alcohol.2005.07.004
194. Zorrilla EP, Valdez GR, Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (2001) 158(4):374-81. doi:10.1007/s002130100773
195. Allen CD, Lee S, Koob GF, Rivier C. Immediate and prolonged effects of alcohol exposure on the activity of the hypothalamic-pituitary-adrenal axis in adult and adolescent rats. Brain Behav Immun (2011) 25(Suppl 1):S50-60. doi:10.1016/j.bbi.2011.01.016
196. Lovallo WR. The hypothalamic-pituitary-adrenocortical axis in addiction. Int J Psychophysiol (2006) 59(3):193-4. doi:10.1016/j.ijpsycho.2005.10.006
197. Jenkins JS, Connolly J. Adrenocortical response to ethanol in man. Br Med J (1968) 2(5608):804-5. doi:10.1136/bmj.2.5608.804
198. King A, Munisamy G, Wit H, Lin S. Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol (2006) 59(3):203-9. doi:10.1016/j.ijpsycho.2005.10.008
199. AdinoffB, Krebaum SR, Chandler PA, Ye W, Morton BB, Williams MJ. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res (2005) 29(4):517-27. doi:10.1097/01.ALC.0000158940.05529.0A
200. AdinoffB, Krebaum SR, Chandler PA, Ye W, Morton BB, Williams MJ. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone. Alcohol Clin Exp Res (2005) 29(4):528-37. doi:10.1097/01.ALC.0000158939.25531.EE
201. Wand GS, Dobs AS. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab (1991) 72(6):1290-5. doi:10.1210/jcem-72-6-1290
202. Errico AL, Parsons OA, King AC, Lovallo WL. Attenuated cortisol response to biobehavioral stressors in sober alcoholics. J Stud Alcohol (1993) 54(4):393-8. doi:10.15288/jsa.1993.54.393
203. Bernardy NC, King AC, Parsons OA, Lovallo WE. Altered cortisol response in sober alcoholics: an examination of contributing factors. Alcohol (1996) 13(5):493-8. doi:10.1016/0741-8329(96)00043-2
204. Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ. Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res (2000) 24(5):651-8. doi:10.1111/j.1530-0277.2000.tb02036.x
205. Margraf HW, Moyer CA, Ashford LE, Lavalle LW. Adrenocortical function in alcoholics. J Surg Res (1967) 7(2):55-62. doi:10.1016/0022-4804(67)90035-2
206. Esel E, Sofuoglu S, Aslan SS, Kula M, Yabanoglu I, Turan MT. Plasma levels of beta-endorphin, adrenocorticotropic hormone and cortisol during early and late alcohol withdrawal. Alcohol Alcohol (2001) 36(6):572-6. doi:10.1093/alcalc/36.6.572
207. Keedwell PA, Poon L, Papadopoulos AS, Marshall EJ, Checkley SA. Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict Biol (2001) 6(3):247-56. doi:10.1080/13556210120056580
208. Majumdar SK, Shaw GK, Bridges PK. Relationship between plasma adrenocorticotrophic hormone and cortisol concentrations in chronic alcoholic patients with depression. Drug Alcohol Depend (1989) 23(2):111-6. doi:10.1016/0376-8716(89)90015-X
209. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 24(2):97-129. doi:10.1016/S0893-133X(00)00195-0
210. Chen ACH, Manz N, Tang Y, Rangaswamy M, Almasy L, Kuperman S, et al. Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. Alcohol Clin Exp Res (2010) 34(6):988-96. doi:10.1111/j.1530-0277.2010.01173.x
211. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 11(6):594-602. doi:10.1038/sj.mp.4001813
212. Blomeyer D, Treutlein J, Esser G, Schmidt MH, Schumann G, Laucht M. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol Psychiatry (2008) 63(2):146-51. doi:10.1016/j.biopsych.2007.04.026
213. Schmid B, Blomeyer D, Treutlein J, Zimmermann US, Buchmann AF, Schmidt MH, et al. Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. Int J Neuropsychopharmacol (2010) 13(6):703-14. doi:10.1017/S1461145709990290
214. Nelson EC, Agrawal A, Pergadia ML, Wang JC, Whitfield JB, Saccone FS, et al. H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence. Addict Biol (2010) 15(1):1-11. doi:10.1111/j.1369-1600.2009.00181.x
215. Vogel F. The genetic basis of the normal human electroencephalogram (EEG). Humangenetik (1970) 10(2):91-114. doi:10.1007/BF00295509
216. Enoch MA, White KV, Harris CR, Robin RW, Ross J, Rohrbaugh JW, et al. Association of low-voltage alpha EEG with a subtype of alcohol use disorders. Alcohol Clin Exp Res (1999) 23(8):1312-9. doi:10.1111/j.1530-0277.1999.tb04352.x
217. Enoch MA, Shen PH, Ducci F, Yuan Q, Liu J, White KV, et al. Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS One (2008) 3(10):e3620. doi:10.1371/journal.pone.0003620
218. Ray LA. Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res (2011) 35(1):166-74. doi:10.1111/j.1530-0277.2010.01333.x
219. Tartter M, Ray L. A prospective study of stress and alcohol craving in heavy drinkers. Pharmacol Biochem Behav (2012) 101(4):625-31. doi:10.1016/j.pbb.2012.03.007
220. Ribbe K, Ackermann V, Schwitulla J, Begemann M, Papiol S, Grube S, et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry (2011) 68(12):1247-56. doi:10.1001/archgenpsychiatry.2011.100